危重症后疼痛及其对日常生活的长期干扰
该队列研究纳入295例成人内科和外科ICU幸存者,用简明疼痛量表评估出院后3和12个月的疼痛强度及对日常生活的干扰。结果显示危重症后持续性疼痛常见且常干扰日常生活,ICU阿片暴露与更差的疼痛症状无关。
要点
- 危重症幸存者出院后3和12个月持续性疼痛报告率分别为77%和74%。
- 疼痛干扰日常生活报告率在3和12个月分别为59%和62%。
- ICU阿片暴露未与疼痛强度或日常生活干扰增加相关。
核心结论
- 危重症后持续性疼痛常见,且频繁干扰日常生活。
- 增加ICU阿片暴露未与更差的疼痛症状相关。
研究设计与样本
- 成人内科和外科ICU幸存者队列研究,共获得295例患者的简明疼痛量表结局。
- 在出院后3和12个月评估疼痛强度及对日常生活的干扰。
- 采用比例优势逻辑回归并Bonferroni校正,调整年龄、入院前阿片使用、衰弱、手术、疾病严重程度及ICU谵妄和脓毒症持续时间等混杂因素。
主要发现
- 3和12个月持续性疼痛症状报告率分别为77%和74%。
- 3和12个月疼痛强度评分中位数(四分位距)均为3(1,5)。
- 3和12个月疼痛干扰日常生活报告率分别为59%和62%,总体干扰评分中位数(四分位距)均为2(0,5)。
临床怎么用
- 对危重症幸存者应关注出院后持续性疼痛及其对日常生活的长期干扰。
- ICU阿片暴露不应被视为持续性疼痛或疼痛干扰的明确危险因素。
局限性
- 需进一步研究识别危重症患者持续性疼痛的可干预危险因素。
- 需进一步研究ICU阿片对有和无慢性疼痛患者的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persistent pain likely interferes with quality of life in survivors of critical illness, but data are limited on its prevalence and risk factors. We sought to determine the prevalence of persistent pain after critical illness and its interference with daily life. Additionally, we sought to determine if intensive care unit (ICU) opioid exposure is a risk factor for its development. METHODS: In a cohort of adult medical and surgical ICU survivors, we used the brief pain inventory (BPI) to assess pain intensity and pain interference of daily life at 3 and 12 months after hospital discharge. We used proportional odds logistic regression with Bonferroni correction to evaluate the independent association of ICU opioid exposure with BPI scores, adjusting for potential confounders including age, preadmission opioid use, frailty, surgery, severity of illness, and durations of delirium and sepsis while in the ICU. RESULTS: We obtained BPI outcomes in 295 patients overall. At 3 and 12 months, 77% and 74% of patients reported persistent pain symptoms, respectively. The median (interquartile range) pain intensity score was 3 (1, 5) at both 3 and 12 months. Pain interference with daily life was reported in 59% and 62% of patients at 3 and 12 months, respectively. The median overall pain interference score was 2 (0, 5) at both 3 and 12 months. ICU opioid exposure was not associated with increased pain intensity at 3 months (odds ratio [OR; 95% confidence interval], 2.12 [0.92-4.93]; P = .18) or 12 months (OR, 2.58 [1.26-5.29]; P = .04). ICU opioid exposure was not associated with increased pain interference of daily life at 3 months (OR, 1.48 [0.65-3.38]; P = .64) or 12 months (OR, 1.46 [0.72-2.96]; P = .58). CONCLUSIONS: Persistent pain is prevalent after critical illness and frequently interferes with daily life. Increased ICU opioid exposure was not associated with worse pain symptoms. Further studies are needed to identify modifiable risk factors for persistent pain in the critically ill and the effects of ICU opioids on patients with and without chronic pain.
引用
- Hayhurst CJ, Jackson JC, Archer KR, et al. Pain and Its Long-term Interference of Daily Life After Critical Illness. Anesth Analg. 2018. PMID: 29649027. doi:10.1213/ANE.0000000000003358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。